Hepatic pseudocystic metastasis of well-differentiated ileal neuroendocrine tumor: a case report with review of the literature
© Fiori et al.; licensee BioMed Central Ltd. 2013
Received: 5 July 2013
Accepted: 4 September 2013
Published: 13 September 2013
Imaging appearance of cyst-like changes is most frequently described in primary neuroendocrine lesions, especially pancreatic NETs.
The imaging finding of a pseudocystic lesion of the liver puts in differential diagnosis many pathologies such as infectious diseases, simple biliary cysts up to biliary cystadenomas and eventually to primary or metastatic malignancies.
Primary or metastatic hepatic malignancies with pseudocystic aspects are rare, and a pseudocystic aspect is reported only after neo-adjuvant treatment.
Liver metastasis of untreated neuroendocrine tumors are usually solid and, to our knowledge, only two cases of neuroendocrine cystic hepatic metastases of ileal atypical carcinoids have been reported so far.
We present a case of a 67 years old man with synchronous finding of an untreated hepatic pseudocystic lesion and an ileal mass histologically diagnosed as a well differentiated (G1) neuroendocrine tumor.
The virtual slides for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/1443883503102967.
KeywordsPseudocystic metastasis Neuroendocrine tumor Hepatic malignancies
Gastro-entero-pancreatic neuroendocrine tumors (NETs) are uncommon, accounting for around 2% of all gastrointestinal tumors [1–3], and are characterized by disparate clinical and pathological features. Their incidence has been on the rise over the last two decades; this, along with an overall good prognostic expectancy, explains the relatively high prevalence estimate of 35/100.000 .
Histopathological characteristics of neuroendocrine carcinomas of the small intestine
Well differentiated (G1- carcinoids)
< 2/10 HPF
Chromogranin A (+)
Moderately differentiated (G2)
May be present
May be present
Chromogranin A (+)
Poorly differentiated (G3 - neuroendocrine carcinoma)
> 20/10 HPF
Chromogranin A (−/+)
Ki67 labeling index cut off of 3% allows the division of NETs in well-differentiated and moderately differentiated and it predicts metatasis or recurrence .
Synaptophysin and Chromogranin A are the most useful markers to differentiate NETs from non-endocrine poorly differentiated adenocarcinoma .
Small bowel is the most common site of presentation of gastrointestinal NETs (44.7%), followed by rectum (19.6%), colon (17%), appendix (16.7%), pancreas (12.1%) and stomach (8.9%) .
The most frequent site of metastases of gastrointestinal NETs, apart from regional lymphnodes, is the liver: hepatic metastases are found at the time of diagnosis in up to 40% of ileal and 80% of caecal lesions . Furthermore, 59–80% of patients with pancreatic non-insulinoma tumors bear synchronous liver metastases . In a minority (5–14%) of patients with NET liver metastases, the primary tumor can’t be identified.
An aggressive surgical management of neuroendocrine hepatic metastases has been demonstrated to improve 5-years survival rates , hence the importance of an accurate histological diagnosis.
Liver metastases are usually solid with a dense capillary network; thereby, computerized tomography (CT) and magnetic resonance (MR) scans reveal hypervascularization with arterial phase enhancement.
A small minority of hepatic NET metastases have a cystic appearance at standard cross-sectional scans, and may be mistaken for benign lesions. Cystic changes, due to central tumor necrosis, are described in NET hepatic metastases as a result of chemotherapic treatment.
A primary cystic appearance is exceedingly rare in untreated cases. At the best of our knowledge, only two other cases of cystic hepatic metastases of untreated ileal NETs have been reported [12, 13].
We present a case of a 67 years old man with synchronous finding of a hepatic pseudocystic lesion and an ileal mass, histologically diagnosed as a well differentiated (G1) NET.
A 67 years old man was referred to our attention for an incidental finding (during routine abdominal ultrasonography) of four hepatic lesions. He had a history of hypertension, ischemic cardiomyopathy, chronic obstructive pulmonary disease and prostatic nodular hyperplasia.
Ultrasonography showed that three lesions, in segments III and VII, were solid, less than 2 cm in diameter; the fourth one, in segment VII, was a 9 cm multilocular cyst with mixed echostructure (hyperechogenic with fluid content).
The cyst showed a portal-phase enhancement in walls and inner septa. Moreover, a 3 cm thickening of terminal ileum wall, and an enlarged (cm 1.5) mesenteric lymphnode were highlighted.
A pan-colonoscopy confirmed the ileo-caecal mass. Histological examination of the endoscopic biopsy specimens was consistent with a well differentiated (G1) NET. Immunostaining for both Synaptophysin and Chromogranin A turned out positive. Afterwards, a fine-needle biopsy of a III segment nodular lesion was performed: histological diagnosis was of well-differentiated (G1) NET hepatic metastasis.
The patient underwent a synchronous right hemicolectomy, left hepatic lobectomy, VII segment resection and cholecystectomy with concurrent radiofrequency ablation of the subcentimetric hepatic nodules. Postoperative course was regular, and a medical regimen of somatostatin analogs (SSAs) was started.
Gross examination and histology
Mitotic count was lower than 2/10 HPF, and Ki67 proliferative index (Ventana, clone 30–9) turned out 1% in both primary and metastatic lesions. All the described lesions showed a positive reaction to Synaptophysin (Ventana, clone MRQ-40) and Chromogranin A (Ventana, clone LK2H10).
Moreover, immunohistochemical stainings for Insulin (DAKO, clone IN-05), Glucagon (DAKO, clone A56501), VIP (Sigma Aldrich, polyclonal) and Serotonin (DAKO, clone 5HT-H209) were performed: only Serotonin stained weakly positive in the ileal mass and in the cystic lesion (Figure 4C and 4D).
According to the 2010 World Health Organization (WHO) Classification of Tumors of the Digestive System , the final diagnosis was of well differentiated (G1) neuroendocrine tumor of the ileum, with hepatic and nodal metastases. Pathological stage, in agreement with the TNM classification of malignant tumors (VII edition, 2009) was pT3, N1, M1. Clinical stage was IV.
Post operative outcome and follow-up
The patient was discharged without complications after fifteen days of recovery. Nine months later he is in good health, with no evidence of residual disease and under a medical regimen of long-acting SSAs.
Hepatic neoplasms with cystic features are rare .
The imaging finding of a pseudocystic lesion of the liver, in absence of clinical symptoms, implies several differential diagnoses, ranging from infectious diseases such as echinococcal cysts , benign lesions as simple biliary cysts and biliary cystadenomas, up to primary or metastatic malignancies.
However, this is the first case of a G1 NET that provoked pseudocystic hepatic metastasis. Hepatic pseudocystic secondarisms are also reported from uterine cervical carcinoma , spinal haemangiopericytoma  and nasopharyngeal carcinoma .
Neuroendocrine tumors can undergo pseudocystic metastases in different sites: a cerebral cystic metastasis of neuroendocrine carcinoma, with unknown primary tumor, has been reported .
Cystic changes are often reported in liver malignancies after a neo-adjuvant treatment. This is thought to be due to therapy-induced tumor necrosis .
A pseudocystic appearance with a peculiar peripheral contrast enhancement are described in pancreatic NETs  and in a case of a case of primary micro-neuroendocrine tumor arising in a horseshoe kidney .
Primary cystic NETs display a less frequent tendency to undergo nodal and hepatic spread when compared to solid counterparts.
We observed an aggressive behaviour, with multiple hepatic and nodal metastases in a well differentiated (G1) ileal NET at the time of diagnosis.
In our case, once the neuroendocrine nature of the primary ileal mass was histologically confirmed, the 111In-pentetreotide somatostatin receptor scintigraphy revealed the same capitation pattern in the hepatic cyst, suggesting its secondary nature. Taking account on these acknowledgements, a complete resection of the cyst was performed. Neo-adjuvant chemotherapy was not performed, despite the advanced clinical stage .
Both macroscopic and microscopic examination showed that the pseudocystic appearance of this metastasis was not due to the central necrosis, but to intratumoral haemorrhage.
All the described findings were incidental, and patient did not complain for pain, flushing, diarrhea or other symptoms related to a ‘’hypersecretion syndrome”. For this reason, the hepatic pseudocyst could have been misdiagnosed, unless an ileal mass was identificated and raised the suspicion for a metastatic NET.
A complete resection of NET hepatic metastases leads to an improved prognostic outcome: 5-years overall survival rates higher than 70%  are reported, despite recurrences develop in up to 80% of patients . Thus, the rationale to remove NET liver metastases, once technically feasible, is established. In order to either obtain an accurate pre-treatment assessment and plan an adequate surgical strategy, it is crucial to differentiate liver NET metastases from other primary or secondary hepatic malignancies (that may not take advantage of the similar prognostic improvements), as well as from benign lesions. For these reasons, we recommend to keep in consideration unusual NET presentations, such as the described one.
Written informed consent was obtained from the patient for publication of this Case Report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
- Estermann F, Thiebault S, Turnani C, Djabri M, Wiedemann R, Sondag D: Pseudocystic metastases of carcinoma of the uterine cervix mimicking polycystic liver disease. Gastroenterol Clin Biol. 1996, 12: 1125-1128.
- Balibrea JM, Rovira-Argelagués M, Otero-Piñeiro AM, Julián JF, Carrato C, Navinés J, Sánchez MC, Fernández-Llamazares J: Multifocal hepatic cystic mass as first manifestation of metastatic spinal hemangiopericytoma. Int J Surg Case Rep. 2013, 1: 15-18.View Article
- Radhakrishnan V, Thulkar S, Karunanithi S, Tanveer N, Bakhshi S: Nasopharyngeal carcinoma with splenic and cystic liver metastases in a pediatric patient: 18F-FDG PET-CT findings. Pediatr Radiol. 2010, 40 (Suppl 1): S79-S82.View ArticlePubMed
- Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, Mares JE, Abdalla EK, Fleming JB, Vauthey JN, Rashid A, Evans DB: One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol. 2008, 26 (18): 3063-3072. 10.1200/JCO.2007.15.4377.View ArticlePubMed
- Bosman FT, Carneiro F, Hruban RH, Theise ND: WHO classification of tumours of the digestive system. 2010, Lyon: IARC
- Yamaguchi T, Fujimori T, Shigeki Tomita T, Ichikawa K, Mitomi H, Ohno K, Shida K, Kato H: Clinical validation of the gastrointestinal NET grading system: Ki67 index criteria of the WHO 2010 classification is appropriate to predict metastasis or recurrence. Diagn Pathol. 2013, 8: 65-10.1186/1746-1596-8-65.PubMed CentralView ArticlePubMed
- El Demellawy DA, Khalifa M, Ismiil N, Wong S, Ghorab Z: Primary colorectal small cell carcinoma: a clinicopathological and immunohistochemical study of 10 cases. Diagn Pathol. 2007, 2: 35-10.1186/1746-1596-2-35.PubMed CentralView ArticlePubMed
- Modlin IM, Lye KD, Kidd M: A 5-decade analysis of 13,715 carcinoid tumors. Cancer. 2003, 97: 934-959. 10.1002/cncr.11105.View ArticlePubMed
- Steinmüller T, Kianmanesh R, Falconi M, Scarpa A, Taal B, Kwekkeboom DJ, Frascati Consensus Conference participants, et al.: Consensus guidelines for the management of patients with liver metastases from digestive (neuro) endocrine tumors: foregut, midgut, hindgut, and unknown primary. Neuroendocrinology. 2008, 87: 47-62. 10.1159/000111037.View ArticlePubMed
- Falconi M, Plockinger U, Kwekkeboom DJ, Manfredi R, Korner M, Kvols L, Frascati Consensus Conference; European Neuroendocrine Tumor Society, et al.: Well-differentiated pancreatic non-functioning tumors/carcinoma. Neuroendocrinology. 2006, 84: 196-211. 10.1159/000098012.View ArticlePubMed
- Tsuchikawa T, Hirano S, Tanaka E, Kato K, Matsumoto J, Nakayama T, Tabata Y, Shichinohe T: Surgical strategy for liver metastases of neuroendocrine tumors. Hepatogastroenterology. 2012, 59: 921-923.PubMed
- Isomura T, Kojiro M, Kawano Y, Nakamura S, Naito H, Yoshida K, Nakayama Y, Nakayama T, Kubo Y: Small multiple carcinoid tumors occurring in the ileum with a pseudocystic liver metastasis. Acta Pathol Jpn. 1980, 30: 137-143.PubMed
- Salamone L, McCarthy S, Salem RR: Atypical cystic carcinoid tumors of the liver. J Clin Gastroenterol. 2010, 44: e256-e259. 10.1097/MCG.0b013e3181da7714.View ArticlePubMed
- Wijesuriya SR, Siriwardana R, Deen K: Education and Imaging. Hepatobiliary and pancreatic: carcinoid tumor with cystic liver metastases. J Gastroenterol Hepatol. 2010, 25: 647-View ArticlePubMed
- Silvain C, Besson I, Azaïs O, le Bezu MW, Morichau-Beauchant M: Pseudocystic hepatic metastasis: unusual onset of carcinoid tumor. Dig Dis Sci. 1991, 36: 542-543. 10.1007/BF01298892.View ArticlePubMed
- Shetty PK, Baliga SV, Balaiah K, Gnana PS: Primary hepatic neuroendocrine tumor: an unusual cystic presentation. Indian J Pathol Microbiol. 2010, 53: 760-762. 10.4103/0377-4929.72078.View ArticlePubMed
- Krohn M, Grieser C, Weichert W, Pascher A, Denecke T: Well-differentiated neuroendocrine carcinoma mimicking an echinococcus cyst of the liver in CT-MRI findings with hepatocyte specific contrast material. J Gastrointestin Liver Dis. 2011, 20: 439-442.PubMed
- Weber MA, Lichy M, Reimer P: Space-occupying lesion in the area of the 3rd ventricle. Cerebral pseudocystic metastasis of a neuroendocrine carcinoma of unknown primary tumor. Radiologe. 2002, 42: 392-396. 10.1007/s00117-002-0739-9.View ArticlePubMed
- Elias D, et al.: Resection of liver metastases from a non colorectal primary: indication and results based on 147 monocentric patients. J Am Coll Surg. 1998, 187: 487-493. 10.1016/S1072-7515(98)00225-7.View ArticlePubMed
- Sarmiento JM, Heywood G, Rubin J, Ilstrup DM, Nagorney DM, Que FG: Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival. J Am Coll Surg. 2003, 197: 29-37. 10.1016/S1072-7515(03)00230-8.View ArticlePubMed
- Kawamoto S, Johnson PT, Shi C, Singhi AD, Hruban RH, Wolfgang CL, Edil BH, Fishman EK: Pancreatic neuroendocrine tumor with cystlike changes: evaluation with MDCT. Am J Roentgenol. 2013, 200: W283-W290. 10.2214/AJR.12.8941.View Article
- Zhang Q, Ming J, Zhang S, Qiu X: Primary micro neuroendocrine tumor arising in a horseshoe kidney with cyst: report of a case and review of literature. Diagn Pathol. 2012, 7: 126-10.1186/1746-1596-7-126.PubMed CentralView ArticlePubMed
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.